Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
6.38 USD | -3.77% | +18.15% | +21.06% |
May. 07 | Bioventus Inc. Revises Earnings Guidance for the Full-Year 2024 | CI |
May. 07 | Transcript : Bioventus Inc., Q1 2024 Earnings Call, May 07, 2024 |
Financials (USD)
Sales 2024 * | 543M | Sales 2025 * | 575M | Capitalization | 407M |
---|---|---|---|---|---|
Net income 2024 * | - | Net income 2025 * | 8M | EV / Sales 2024 * | 1.35 x |
Net Debt 2024 * | 328M | Net Debt 2025 * | 276M | EV / Sales 2025 * | 1.19 x |
P/E ratio 2024 * |
-79.1
x | P/E ratio 2025 * |
87.8
x | Employees | 995 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 67.13% |
Latest transcript on Bioventus Inc.
1 day | -3.77% | ||
1 week | +18.15% | ||
Current month | +61.11% | ||
1 month | +40.22% | ||
3 months | +40.84% | ||
6 months | +66.58% | ||
Current year | +21.06% |
Managers | Title | Age | Since |
---|---|---|---|
Robert Claypoole
CEO | Chief Executive Officer | - | Jan. 09 |
Mark Singleton
DFI | Director of Finance/CFO | 55 | 22-03-20 |
Katrina Church
CMP | Compliance Officer | 62 | - |
Members of the board | Title | Age | Since |
---|---|---|---|
William Hawkins
CHM | Chairman | 70 | 16-06-29 |
Guy Nohra
BRD | Director/Board Member | 63 | 19-12-31 |
Martin Sutter
BRD | Director/Board Member | 68 | 16-06-29 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.00% | 9 M€ | +11.05% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-17 | 6.38 | -3.77% | 249,616 |
24-05-16 | 6.63 | +4.41% | 471,370 |
24-05-15 | 6.35 | +6.01% | 541,075 |
24-05-14 | 5.99 | +4.72% | 390,789 |
24-05-13 | 5.72 | +5.93% | 483,959 |
Delayed Quote Nasdaq, May 17, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+21.06% | 407M | |
+73.24% | 12.39B | |
-19.09% | 7.89B | |
+13.24% | 5.43B | |
+38.48% | 4.96B | |
-17.30% | 4.72B | |
-19.78% | 4.02B | |
-29.53% | 2.66B | |
+47.29% | 2.37B | |
-2.10% | 1.96B |
- Stock Market
- Equities
- BVS Stock